Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-778-7 | CAS number: 70693-62-8
Health surveillance data
Administrative data
- Endpoint:
- health surveillance data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1999-2005
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- This study record is taken from the Medical Health Surveillance Department of the manufacturing plant. This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labelling and/or risk assessment.
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
- Study type:
- health record from industry
- Endpoint addressed:
- repeated dose toxicity: inhalation
- repeated dose toxicity: dermal
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Workers of KMPS triple salt production were examined for health effects periodically within 6 years. Examinations included a hearing test, sight test, lung function test, ECG under exercise, blood and urine examinations.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Pentapotassium bis(peroxymonosulphate) bis(sulphate)
- EC Number:
- 274-778-7
- EC Name:
- Pentapotassium bis(peroxymonosulphate) bis(sulphate)
- Cas Number:
- 70693-62-8
- Molecular formula:
- H3K5O18S4
- IUPAC Name:
- pentapotassium bis((hydroperoxysulfonyl)oxidanide) hydrogen sulfate sulfate
- Test material form:
- solid
Constituent 1
Method
- Type of population:
- occupational
- Ethical approval:
- not applicable
- Details on study design:
- see below
Results and discussion
- Results:
- Clinical Signs: No specific effects damaging to health of KMPS triple salt were observed within a period of 6 years.
Results of examinations: No KMPS triple salt-related signs observed.
Effectivity of medical treatment: No medical treatment necessary.
Applicant's summary and conclusion
- Conclusions:
- KMPS triple salt does not have an health effect on workers of the production.
- Executive summary:
Materials and methods
Workers of KMPS triple salt production were examined for health effects periodically within 6 years. Examinations included a hearing test, sight test, lung function test, ECG under exercise, blood and urine examinations.
Results and discussion
No specific effects damaging to health of KMPS triple salt were observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
